Ahana Hospitals LLP is a Neuropsychiatric Hospital that has an integrated clinical research department, that specializes in conducting and enabling novel and systemized research in the field of psychiatry aimed at driving healthcare in a positive direction. The endeavor of the clinical research unit is to undertake and promote excellence in clinical research and foster and support patient care and treatment. In line with Ahana Hospitals’ high ethical standards, the clinical trials are conducted in compliance with regulatory requirements that ensure and protect the safety, well-being, and rights of the subjects.
Our site has conducted more than 40 trials in phases II, III, IV, and BA-BE – global and multi-centric trials for over a decade now. The site has been inspected by the US FDA. We’ve done clinical trials on the following indications: Major depressive disorder, Schizophrenia, Premature ejaculation, Bipolar disorder, Adolescent Schizophrenia, Depression with Anxiety disorder
All the team members have been trained according to ICH-GCP guidelines, ICMR guidelines and NDCT rules 2019.
|Team Members||Team Member Count|
All the instruments are regularly calibrated.
The ethical aspects of the trials are collectively monitored and reviewed by our Central Drugs Standard Control Organization (CDSCO) registered Institutional Ethics Committee. The IEC is responsible for scientific, ethical, and regulatory oversight of research conducted at Ahana Hospitals and serves to protect the rights and welfare of human subjects. In Addition to it, the IEC reviews and approves academic research projects conducted by the Ahana hospitals.